ClariVest Asset Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-153,401
Closed -$4.03M 712
2017
Q2
$4.03M Buy
153,401
+1,292
+0.8% +$31.8K 0.1% 192
2017
Q1
$3.56M Buy
152,109
+27,714
+22% +$684K 0.09% 210
2016
Q4
$3.13M Buy
124,395
+48,583
+64% +$1.23M 0.08% 192
2016
Q3
$2.13M Buy
75,812
+76
+0.1% +$1.95K 0.06% 204
2016
Q2
$1.87M Sell
75,736
-1,237
-2% -$30.7K 0.06% 217
2016
Q1
$1.7M Sell
76,973
-30,100
-28% -$801K 0.05% 221
2015
Q4
$3.75M Buy
107,073
+6,791
+7% +$213K 0.11% 114
2015
Q3
$2.85M Sell
100,282
-8,663
-8% -$291K 0.09% 145
2015
Q2
$3.63M Buy
108,945
+2,600
+2% +$79.8K 0.11% 131
2015
Q1
$3M Buy
106,345
+7,532
+8% +$187K 0.09% 140
2014
Q4
$2.05M Sell
98,813
-12
-0% -$285 0.07% 160
2014
Q3
$2.41M Buy
98,825
+56,360
+133% +$1.49M 0.09% 148
2014
Q2
$1.21M Buy
42,465
+23,586
+125% +$656K 0.05% 223
2014
Q1
$528K Sell
18,879
-5,153
-21% -$127K 0.02% 265
2013
Q4
$517K Sell
24,032
-21,128
-47% -$384K 0.02% 274
2013
Q3
$599K Sell
45,160
-23,899
-35% -$322K 0.03% 253
2013
Q2
$957K Buy
+69,059
New +$979K 0.04% 211

Other funds holding PMC

ClariVest Asset Management's PMC Position: Q3 2017 in Review

ClariVest Asset Management sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 153,401 shares — an estimated $4.03M sold.

ClariVest Asset Management first reported a position in PMC in Q2 2013 and held it in 17 quarters. The position peaked at $4.03M in Q2 2017. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • ClariVest Asset Management reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • ClariVest Asset Management sold 153,401 PharMerica Corporation shares in Q3 2017, an estimated $4.03M.
  • ClariVest Asset Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 17 quarters.
  • ClariVest Asset Management's PharMerica Corporation position peaked at $4.03M in Q2 2017.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on ClariVest Asset Management's 13F filing for Q3 2017, filed 7 Nov 2017.